Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × siltuximab × Other hematologic neoplasm × Clear all

Phase

Status

Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 96 Cyclophosphamide 66 fludarabine 38 Idarubicin 34 Decitabine 32 Etoposide 30 Azacitidine 30 Methotrexate 28 Vincristine 26 Daunorubicin 26 Dexamethasone 24 Busulfan 23 venetoclax 22 Radiotherapy 21 Imatinib Mesylate 21 Mercaptopurine 19 Peripheral Blood Stem Cell Transplantation 17 Dasatinib 17 Doxorubicin 16 Immunotherapy, Adoptive 15 fludarabine phosphate 14 Rituximab 14 Mitoxantrone 14 Granulocyte Colony-Stimulating Factor 14 Asparaginase 13 Prednisone 12 Melphalan 12 Cyclosporine 12 Tretinoin 11 Prednisolone 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05697510 2023-04-06

SILTUXILAM

Nantes University Hospital

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡